Picture of XBiotech logo

XBIT — XBiotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: XBiotech Developing Novel True Human Antibody Targeting Interleukin-1Alpha

April 14 (Reuters) - XBiotech Inc  XBIT.O :
    * XBIOTECH DEVELOPING NOVEL TRUE HUMAN ANTIBODY TARGETING
INTERLEUKIN-1ALPHA (IL-1⍺)
    * XBIOTECH INC - ON SCHEDULE TO REENTER CLINIC WITH A NEW
ANTI-IL-1⍺ THERAPY IN 2021

Source text for Eikon:  ID:nGNX3dnfJb 
Further company coverage:  XBIT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on XBiotech

See all news